Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Pharmacokinetics-Pharmacodynamics (PK-PD) Profile, Effectiveness and Safety of ATM-AVI in Special Populations
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Impact of Rapid Diagnostic Tests (RDTs) on Treatment Pattern and Outcomes in Patients with Carbapenem-Resistant (CR) Pathogens
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Global Request for Proposals – Pfizer Clostridioides difficile (C. difficile) Research Collaboration
    Release Date:
    Review Process: Pfizer Internal
    Call for Collaborator(s) Vaccines France, Germany
    Initiatives to Improve the Clinical Environment for Dermatologic Immunology, Inflammation, and Allergy Care
    Release Date:
    Partner: The Japanese Society for Cutaneous Immunology and Allergy
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Inflammation & Immunology Japan
    Real World, Long-term Efficacy Study of Ritlecitinib in Adult and Adolescent Patients with Severe Alopecia Areata in China
    Release Date:
    Review Process: Pfizer Internal
    Research Inflammation & Immunology China
    Epidemiology and surveillance of Gram-negative infections caused by carbapenemase-producing organisms (CPOs) in the UK
    Release Date:
    Review Process: Expert Review Panel
    Research Internal Medicine United Kingdom
    Advancing Care for Patients with Advanced ALK+ Non-Small Cell Lung Cancer (NSCLC)
    Release Date:
    Partner: ALK Positive
    Review Process: Pfizer Internal
    Education Oncology All
    Quality Improvement Solutions for the Diagnosis and Management of Migraine and Headache Disorders
    Release Date:
    Partner: American Headache Society
    Review Process: Expert Review Panel
    Quality Improvement Internal Medicine Canada, USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Release Date:
    Review Process:
    Use of PROS in RA
    Release Date:
    Attention-Deficit/Hyperactivity Disorder
    Release Date:
    Symptomatic Vulvovaginal Atrophy in the Postmenopausal Woman
    Release Date:
    Chronic Pain Care Outcomes
    Release Date:
    Chronic Pain Care in the Patient-Centered Medical Home
    Release Date:
    Medication-Overuse Headache (MOH)
    Release Date:
    Reducing Cardiovascular Risk Globally Through Improved Dyslipidemia Awareness and Treatment
    Release Date:
    Community Oncologist Education and Support Systems ‐ Renal Cell Carcinoma and Hematologic Malignancies
    Release Date:
    Disparities in Adult Immunizations
    Release Date:
    Global Bridges Smoking Cessation
    Release Date:
    Advances in Anticoagulation (Pfizer and BMS)
    Release Date:
    Review Process: